ADMESeq™ panel simultaneously targets 242 known pharmacogenetic genes in a single assay LEXINGTON, Mass. and ALISO VIEJO, Calif. – October 24, 2011 – RainDance Technologies, Inc., the Digital Biology™ Company, and Ambry Genetics, today announced the launch of a comprehensive targeted
ATLANTA – October 18, 2011 – Geneticists at Emory University School of Medicine have demonstrated a method that enables the routine amplification of all the genes on the X chromosome. The technology allows the rapid and highly accurate sequencing and identification of novel genetic va
Fully automated high-throughput platform enables researchers to process more samples and generate high-quality data faster and easier than ever before LEXINGTON, Mass. and MONTREAL, Canada – October 11, 2011 – RainDance Technologies, Inc., the Digital Biology™ Company, today announced
RainDance Technologies® is making complex genetics simple. The company’s ultra-sensitive genomic tools enable research of novel non-invasive liquid biopsy applications that should result in more accurate, reliable, cost-effective, and early detection of cancer and other inherited and infectious diseases. Major research institutions and laboratories around the world rely on the performance of RainDance systems. Based outside Boston, Massachusetts, the company supports customers using RainDrop® Digital PCR, as well as the ThunderStorm® and ThunderBolts™ Next-Generation Sequencing Enrichment Systems through its international sales and service operations, as well as a global network of distributors and commercial service providers. Both technology platforms have been recognized by The Scientist as Top 10 Innovations with the RainDrop System winning the award in 2014 and the ThunderStorm System winning the award in 2011.